This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effects of early abiraterone acetate in combination with androgen deprivation therapy for newly diagnosed metastatic hormone-sensitive prostate cancer.
Bibliographical notePublisher Copyright:
© 2019 The Cochrane Collaboration.
Copyright 2019 Elsevier B.V., All rights reserved.